MULTIFOCAL MOTOR NEUROPATHY
Clinical trials for MULTIFOCAL MOTOR NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL MOTOR NEUROPATHY trials appear
Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could reduce need for infusions in nerve disorder
Disease control OngoingThis Phase 2 trial tests a drug called claseprubart (DNTH103) in 36 adults with multifocal motor neuropathy, a rare nerve condition that causes muscle weakness. Participants receive either the drug or a placebo for 15 weeks. The study looks at safety, how the drug works in the bo…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Major study launches to unravel the Real-World impact of rare nerve disease
Knowledge-focused OngoingThis study follows about 413 adults with multifocal motor neuropathy (MMN) over time to learn how the disease progresses and affects daily life. Researchers will collect information on symptoms, quality of life, and healthcare use during regular doctor visits. No experimental tre…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY
Sponsor: argenx • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC